Prophylactic use of antibiotics for cancer inpatients with leukocyte count ≤1×109/L
SUN Jia-Teng, JIA Shi-Jing, JU Gui-Fang, RONG Yue, WU Di
Medicine and Life Sciences College of Shandong Academy of Medical Sciences,Ji′nan University & The Six Department of Radiation Oncology, Shandong Cancer Hospital & Institute, Ji′nan 250117, China
SUN Jia-Teng, JIA Shi-Jing, JU Gui-Fang, RONG Yue, WU Di. Prophylactic use of antibiotics for cancer inpatients with leukocyte count ≤1×109/L[J]. Journal of International Oncology, 2016, 43(2): 103-.
[1] 詹亚杰,赵莹.2402例肿瘤化疗患者医院感染分析及预防措施[J].北华大学学报:自然科学版,2011,12(4):434437.
[2] Caggiano V, Weiss RV, Rickert TS, et al. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy[J]. Cancer, 2005, 103(9): 19161924. DOI: 10.1002/cncr.20983.
[3] 杨祺,李朝霞,徐婷.肿瘤化疗患者感染病原菌分布及危险因素分析[J].中华医院感染学杂志,2014,24(20):50085009.
[4] Aapro MS, Bohlius J, Cameron DA, et al. 2010 update of EORTC guidelines for the use of granulocytecolony stimulating factor to reduce the incidence of chemotherapyinduced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours[J]. Eur J Cancer, 2011, 47(1): 832. DOI: 10.1016/j.ejca.2010.10.013.
[5] 张家会,鄢丽霞,吴秀,等.白血病人化疗后实施保护性隔离预防感染的效果评价[J].现代生物医学进展,2014,(17):33383340.DOI: 10.13241/j.cnki.pmb.2014.17.036.
[6] Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2011, 52(4): 427431. DOI: 10.1093/cid/ciq147.
[7] Penack O, Becker C, Buchheidt D, et al. Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)[J]. Ann Hematol, 2014, 93(7): 10831095. DOI: 10.1007/s0027701420860.
[8] 张锦林,倪美鑫,季屹红,等.肿瘤专科医院恶性肿瘤患者医院感染的调查分析[J].中华医院感染学杂志,2011,21(7):13341336.